RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: Nov 22, 2024, 4:00 PM
1.100
+0.020 (1.85%)
After-hours: Nov 22, 2024, 7:42 PM EST
RAPT Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 37.9 | 47.48 | 38.95 | 24.03 | 24.92 | 77.38 | Upgrade
|
| Short-Term Investments | 60.01 | 111.38 | 210.12 | 165.63 | 86.59 | - | Upgrade
|
| Cash & Short-Term Investments | 97.91 | 158.86 | 249.07 | 189.65 | 111.51 | 77.38 | Upgrade
|
| Cash Growth | -47.01% | -36.22% | 31.33% | 70.08% | 44.10% | 21.29% | Upgrade
|
| Prepaid Expenses | 4.69 | 2.92 | 3.63 | 3.32 | 4.09 | 3.12 | Upgrade
|
| Total Current Assets | 102.6 | 161.78 | 252.69 | 192.97 | 115.6 | 80.51 | Upgrade
|
| Property, Plant & Equipment | 5.48 | 7.68 | 9.48 | 2.74 | 2.98 | 3.71 | Upgrade
|
| Other Long-Term Assets | 0.39 | 3.87 | 4.04 | 2.92 | 0.39 | 0.39 | Upgrade
|
| Total Assets | 108.47 | 173.33 | 266.21 | 198.64 | 118.97 | 84.6 | Upgrade
|
| Accounts Payable | 1.38 | 5.18 | 3.37 | 2 | 2.38 | 1.14 | Upgrade
|
| Accrued Expenses | 6.4 | 14.1 | 8.66 | 6.33 | 4.94 | 3.64 | Upgrade
|
| Current Portion of Leases | 2.52 | 2.45 | 2.17 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 1.02 | 4.1 | 4 | Upgrade
|
| Other Current Liabilities | 0.06 | 0.11 | 0.03 | 0.25 | 0.33 | 0.47 | Upgrade
|
| Total Current Liabilities | 10.36 | 21.84 | 14.22 | 9.6 | 11.74 | 9.26 | Upgrade
|
| Long-Term Leases | 2.6 | 4.46 | 6.82 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 0.51 | 0.86 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 2.15 | 2.19 | 2.23 | Upgrade
|
| Total Liabilities | 12.96 | 26.29 | 21.04 | 12.26 | 14.79 | 11.48 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 656.69 | 631.61 | 613.07 | 470.63 | 319.2 | 235.05 | Upgrade
|
| Retained Earnings | -561.3 | -484.68 | -367.88 | -284.05 | -214.84 | -161.95 | Upgrade
|
| Comprehensive Income & Other | 0.11 | 0.1 | -0.03 | -0.21 | -0.18 | 0.02 | Upgrade
|
| Total Common Equity | 95.51 | 147.04 | 245.17 | 186.38 | 104.18 | 73.12 | Upgrade
|
| Shareholders' Equity | 95.51 | 147.04 | 245.17 | 186.38 | 104.18 | 73.12 | Upgrade
|
| Total Liabilities & Equity | 108.47 | 173.33 | 266.21 | 198.64 | 118.97 | 84.6 | Upgrade
|
| Total Debt | 5.12 | 6.91 | 8.99 | - | - | - | Upgrade
|
| Net Cash (Debt) | 92.79 | 151.96 | 240.08 | 189.65 | 111.51 | 77.38 | Upgrade
|
| Net Cash Growth | -47.67% | -36.71% | 26.59% | 70.08% | 44.10% | 21.29% | Upgrade
|
| Net Cash Per Share | 2.40 | 3.96 | 7.38 | 6.92 | 4.62 | 17.80 | Upgrade
|
| Filing Date Shares Outstanding | 34.96 | 34.8 | 34.29 | 29.57 | 24.87 | 24.33 | Upgrade
|
| Total Common Shares Outstanding | 34.9 | 34.4 | 34.25 | 29.56 | 24.77 | 21.83 | Upgrade
|
| Working Capital | 92.24 | 139.95 | 238.47 | 183.38 | 103.86 | 71.25 | Upgrade
|
| Book Value Per Share | 2.74 | 4.27 | 7.16 | 6.31 | 4.21 | 3.35 | Upgrade
|
| Tangible Book Value | 95.51 | 147.04 | 245.17 | 186.38 | 104.18 | 73.12 | Upgrade
|
| Tangible Book Value Per Share | 2.74 | 4.27 | 7.16 | 6.31 | 4.21 | 3.35 | Upgrade
|
| Machinery | 8.15 | 8.52 | 7.49 | 7.13 | 6.77 | 6.47 | Upgrade
|
| Leasehold Improvements | 3.3 | 3.3 | 3.3 | 3.3 | 3.29 | 3.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.